NEW! If you don't understand one of the words in this article,
just double-click it.
A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature
doesn't work in your browser, you can enter the word below:
Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.
November 19, 2007
Brazil Commended for Its AIDS Policy
Researchers at the Harvard School of Public Health applaud Brazil’s AIDS policy—which has included lowering the price of HIV/AIDS medications and making generic versions more available—in a new study published in the November 13 Public Library of Science journal (newsvote.bbc.co.uk, 11/14).
Researchers describe Brazil’s work in dealing with the epidemic as “remarkable,” noting that its AIDS policy has saved the country around $1 billion between 2001 and 2005. In 1996, Brazil became the first country to pledge to provide free and universal access to HIV medications to its HIV-positive population, and remains committed to safe-sex messaging despite the continued conservative stance of many other Latin American governments.
Brazil currently produces generic versions of eight HIV medications that do not currently have patents. Earlier this year, Brazil broke the patent on Efavirenz and imported a cheaper version of the drug from India.
